Loading…
Lobbying Spend
—
Filings
28
Firms Hired
1
Active Period
2011–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2017 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease S. 1878, the Advancing Hope Act 21st Century Cures - advancing cures for orphan diseases
Client expense: — · Firm income: —
Matched citations: S. 1878
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2017 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease S. 1878, the Advancing Hope Act
Client expense: — · Firm income: —
Matched citations: S. 1878
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2017 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease S. 1878, the Advancing Hope Act
Client expense: — · Firm income: —
Matched citations: S. 1878
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2017 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease S. 1878, the Advancing Hope Act
Client expense: — · Firm income: —
Matched citations: S. 1878
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · fourth_quarter · Firm: STANTON PARK GROUP
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2016 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease HR 3020/S 1695, the FY2016 Labor HHS Appropriations Act
Client expense: — · Firm income: —
Matched citations: HR 3020
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · fourth_quarter · Firm: STANTON PARK GROUP
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2016 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease HR 3020/S 1695, the FY2016 Labor HHS Appropriations Act
Client expense: — · Firm income: —
Matched citations: S 1695
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · third_quarter · Firm: STANTON PARK GROUP
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2016 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease HR 3020/S 1695, the FY2016 Labor HHS Appropriations Act
Client expense: — · Firm income: —
Matched citations: HR 3020
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · third_quarter · Firm: STANTON PARK GROUP
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2016 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease HR 3020/S 1695, the FY2016 Labor HHS Appropriations Act
Client expense: — · Firm income: —
Matched citations: S 1695
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · second_quarter · Firm: STANTON PARK GROUP
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2016 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease HR 3020/S 1695, the FY2016 Labor HHS Appropriations Act
Client expense: — · Firm income: —
Matched citations: HR 3020
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · second_quarter · Firm: STANTON PARK GROUP
NIH research on slow growing PLGA childhood brain tumors; issues impacting pediatric cancer research and treatments; NIH funding in the FY2016 Labor, Health and Education Appropriations Act. Access to therapies and FDA approval pathways for rare disease HR 3020/S 1695, the FY2016 Labor HHS Appropriations Act
Client expense: — · Firm income: —
Matched citations: S 1695
Source: Senate LDA